Related references
Note: Only part of the references are listed.Bromodomain and extra-terminal (BET) family proteins: New therapeutic targets in major diseases
Balasundaram Padmanabhan et al.
JOURNAL OF BIOSCIENCES (2016)
ERK5 Is a Critical Mediator of Inflammation-Driven Cancer
Katherine G. Finegan et al.
CANCER RESEARCH (2015)
Erk5 contributes to maintaining the balance of cellular nucleotide levels and erythropoiesis
Maria Angulo-Ibanez et al.
CELL CYCLE (2015)
A novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4-ERK5 axis
Ling Wu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Extracellular signal-regulated kinase 5 promotes acute cellular and systemic inflammation
Kevin Wilhelmsen et al.
SCIENCE SIGNALING (2015)
Extracellular signal-regulated kinase 5 promotes acute cellular and systemic inflammation
Kevin Wilhelmsen et al.
SCIENCE SIGNALING (2015)
The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma
Elisabetta Rovida et al.
GUT (2015)
Phosphorylation of ERK5 on Thr732 Is Associated with ERK5 Nuclear Localization and ERK5-Dependent Transcription
Takuto Honda et al.
PLOS ONE (2015)
Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors
Stuart W. J. Ember et al.
ACS CHEMICAL BIOLOGY (2014)
A positive feedback loop involving Erk5 and Akt turns on mesangial cell proliferation in response to PDGF
Amit Bera et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)
IL-17 in Severe Asthma Where Do We Stand?
Julie Chesne et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Monitoring Native p38α:MK2/3 Complexes via Trans Delivery of an ATP Acyl Phosphate Probe
Eric S. Okerberg et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
Pietro Ciceri et al.
NATURE CHEMICAL BIOLOGY (2014)
Targeting bromodomains: epigenetic readers of lysine acetylation
Panagis Filippakopoulos et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Regulation of MYC Expression and Differential JQ1 Sensitivity in Cancer Cells
Trent Fowler et al.
PLOS ONE (2014)
Cyclin-Dependent Kinase Inhibitor Dinaciclib Interacts with the Acetyl-Lysine Recognition Site of Bromodomains
Mathew P. Martin et al.
ACS CHEMICAL BIOLOGY (2013)
Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains
Olivier Mirguet et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
ERK5 and its role in tumour development
Pamela A. Lochhead et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia
Christopher J. Ott et al.
BLOOD (2012)
ERK5: Structure, regulation and function
Gopika N. Nithianandarajah-Jones et al.
CELLULAR SIGNALLING (2012)
ERK5 Protein Promotes, whereas MEK1 Protein Differentially Regulates, the Toll-like Receptor 2 Protein-dependent Activation of Human Endothelial Cells and Monocytes
Kevin Wilhelmsen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Inducible and Conditional Deletion of Extracellular Signal-regulated Kinase 5 Disrupts Adult Hippocampal Neurogenesis
Yung-Wei Pan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins
William W. Lockwood et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
MAP Kinase Pathways
Deborah K. Morrison
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Inhibition of MEK5 by BIX02188 induces apoptosis in cells expressing the oncogenic mutant FLT3-ITD
Elena Razumovskaya et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
The secret life of kinases: functions beyond catalysis
Jens Rauch et al.
CELL COMMUNICATION AND SIGNALING (2011)
In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases
Matthew P. Patricelli et al.
CHEMISTRY & BIOLOGY (2011)
Discovery of a benzo[e]pyrimido-[5,4-b][1,4]diazepin-6(11H)-one as a Potent and Selective Inhibitor of Big MAP Kinase 1
Xianming Deng et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
Pharmacological Inhibition of BMK1 Suppresses Tumor Growth through Promyelocytic Leukemia Protein
Qingkai Yang et al.
CANCER CELL (2010)
Alternative ERK5 regulation by phosphorylation during the cell cycle
Francisco A. Inesta-Vaquera et al.
CELLULAR SIGNALLING (2010)
Multisite phosphorylation of Erk5 in mitosis
Elena Diaz-Rodriguez et al.
JOURNAL OF CELL SCIENCE (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Activation of a C-terminal transcriptional activation domain of ERK5 by autophosphorylation
Hiroko Morimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Regulation of the G2-M cell cycle progression by the ERK5-NFκB signaling pathway
Kelly Cude et al.
JOURNAL OF CELL BIOLOGY (2007)
Functional interrogation of the kinome using nucleotide acyl phosphates
Matthew P. Patricelli et al.
BIOCHEMISTRY (2007)
A module of negative feedback regulators defines growth factor signaling
Ido Amit et al.
NATURE GENETICS (2007)
Regulation of nuclear translocation of extracellular signal-regulated kinase 5 by active nuclear import and export mechanisms
K Kondoh et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Transcriptional regulation of tissue-specific genes by the ERK5 mitogen-activated protein kinase
SJ Sohn et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Multifunctional role of Erk5 in multiple myeloma
X Carvajal-Vergara et al.
BLOOD (2005)
Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure
M Hayashi et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
An analysis of the phosphorylation and activation of extracellular-signal-regulated protein kinase 5 (ERK5) by mitogen-activated protein kinase kinase 5 (MKK5) in vitro
N Mody et al.
BIOCHEMICAL JOURNAL (2003)
Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects
CP Regan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Modulation of bronchial epithelial cells by IL-17
M Kawaguchi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
IL-17-induced cytokine release in human bronchial epithelial cells in vitro:: role of mitogen-activated protein (MAP) kinases
M Laan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
ERK5 is a novel type of mitogen-activated protein kinase containing a transcriptional activation domain
HG Kasler et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
